Organization
The Affiliated Drum Tower Hospital of Nanjing University Medical School
26 clinical trials
2 abstracts
Abstract
Geographic and sociodemographic variations in disease burden, epidemiological trends, and risk factors of early-onset lung cancer: A global analysis.Org: Department of Thoracic Oncology and Surgery, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine,
Clinical trial
A Prospective, Randomized, Open Label, Parallel, 76-week Study to Explore and Evaluate the Therapeutic Effects ofLiraglutide, Empagliflozin and Linagliptin on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in T2DM Patients With Mild Cognitive Impairment.Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Perioperative Application of Liraglutide for the Prevention of Postoperative Delirium Among Elderly Patients With Type 2 Diabetes Undergoing Cardiac Surgery: A Single-Center Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
A Prospective, Randomized, Open Label, Parallel, 6-month Study to Explore and Evaluate the Therapeutic Effects of Henagliflozin on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in T2DM Patients With Mild Cognitive Impairment.Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
A Multicenter Study of Penpulimab and Anlotinib in Combination With Nab-paclitaxel Plus Gemcitabine as First-line Therapy in Patients (Pts) With Metastatic Pancreatic Cancer: PAAG.Status: Completed, Estimated PCD: 2024-05-01
Clinical trial
A Prospective Single-center, Single-arm Clinical Study of the PD-1 Inhibitor Tislelizumab Combined With APF Sequential Surgery or Radical Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Head and Neck TumorsStatus: Recruiting, Estimated PCD: 2024-06-07
Clinical trial
Efficacy and Safety of Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary CarcinomaStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
A Single-arm, Exploratory Clinical Study of Trilaciclib Combined With mFOLFIRINOX Regimen in the Treatment of Patients With Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-05-28
Clinical trial
Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer: a Single Arm, Open Label, Phase II Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer: a Prospective, Single-arm, Phase II TrialStatus: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
A Single-center, Randomized, Controlled, Single-blind Study Evaluating the Efficacy and Safety of Sivelestat Sodium in Preventing Postoperative Acute Respiratory Distress Syndrome Following Cardiac SurgeryStatus: Not yet recruiting, Estimated PCD: 2026-06-30
Clinical trial
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer: a Prospective, Multicenter, Randomized Controlled Clinical StudyStatus: Recruiting, Estimated PCD: 2028-03-01
Clinical trial
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine (PAAG) as First-line Treatment for Advanced Metastatic Pancreatic Cancer: a Prospective, Multicenter, Single-arm, Phase 2 StudyStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients: a Randomized, Parallel Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
An Open-Label, Multi-Cohort, Two-Stage, Phase Ib/II Clinical Study to Evaluate the Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Treating Advanced Urological TumorsStatus: Not yet recruiting, Estimated PCD: 2025-08-31
Clinical trial
Tislelizumab in Combination With Pre-operative Chemoradiotherapy Versus SOC for Patients With Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: a Multicenter, Randomized, Open-label, Phase IIB TrialStatus: Recruiting, Estimated PCD: 2027-02-28
Clinical trial
Clinical Study of Mesenchymal Stem Cell Eye Drops for Treating Dry Eye DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-07-31
Clinical trial
Study on the Clinical Efficacy and Safety of the New Mineralocorticoid Receptor Antagonist Finerenone in the Treatment of Primary Aldosteronism: a Multicenter, Prospective, Open-label Clinical StudyStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
A Prospective, Multicenter, Single-arm Clinical Study of the Efficacy and Safety of Toripalimab in Combination With Axitinib for Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence FactorsStatus: Recruiting, Estimated PCD: 2026-12-30
Clinical trial
Efficacy and Safety of Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer: A Prospective, Multi-centre StudyStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Adjuvant Androgen Deprivation Therapy Combined With Apalutamide for Prostate Cancer Patients Post Radical-prostatectomy With High-risk of Reoccurrence: a Prospective, Single-arm, Multicenter Trial (ARES Study)Status: Not yet recruiting, Estimated PCD: 2026-08-31
Clinical trial
Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery : a Multi-center, Randomized, Controlled, Double-blind Clinical TrialStatus: Recruiting, Estimated PCD: 2026-08-31
Clinical trial
Efficacy and Safety of Digoxin in the Treatment of Adults Patients With Non-alcoholic Steatohepatitis: a Multi-center, Randomized, Placebo-controlled TrialStatus: Withdrawn, Estimated PCD: 2022-12-01
Clinical trial
Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell CarcinomaStatus: Completed, Estimated PCD: 2023-06-12
Clinical trial
SHR7390 in the Treatment of Metastatic Hormone-Resistant Prostate Cancer That Failed Previous Docetaxel and New Endocrine TherapyStatus: Completed, Estimated PCD: 2023-06-12
Abstract
A phase Ib study of porustobart (HBM4003), an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in patients with hepatocellular carcinoma.Org: Nanjing Tianyishan Hospital, NanFang Hospital of Southern Medical University, Haerbin Medical University Cancer Hospital, The First Affiliated Hospital of Henan University of Science and Technology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China,
Clinical trial
An Exploartory Trial of IMPT-514, An Autologous Anti-CD19/20 CAR T Therapy in Participants With Active, Refractory Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory MyopathyStatus: Not yet recruiting, Estimated PCD: 2025-05-31
Clinical trial
Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer PhenotypeStatus: Not yet recruiting, Estimated PCD: 2026-07-31